Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GW815SF (Salmeterol/Fluticasone) in Pediatric Asthma
NCT00449046Phase 3Completed
- Sponsor
- GSK
- Start
- Mar 2007
- Primary completion
- Nov 2007
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of salmeterol, fluticasone propionate in asthma, sponsored by GSK. Started Mar 2007; status: completed.
02
Drugs
salmeterolfluticasone propionate
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00449046.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00449046.